SomnoMed Limited

SomnoMed Limited

SOMNF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$39.56M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
SomnoMed LimitedSomnoMed Limited-26.4--13%0.20.1
$0.61

Current Fair Value

236.2% upside

Undervalued by 236.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$39.56 Million
Enterprise Value$27.88 Million
Earnings per Share$-0.01
Beta0.8
Outstanding Shares219,193,253

Return

Return on Equity-12.87%ROE
Return on Assets-8.14%
Return on Invested Capital1.29%

Valuation & Multiples

P/E Ratio-26.45P/E Ratio
PEG-1025.81PEG
Price to Sales0.18Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.12
Enterprise Value to EBIT41.83
Enterprise Value to Net Income-5
Total Debt to Enterprise0.2
Debt to Equity0.12Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 27, 2026
EPS
-$0.01
Est. $0.00
Revenue
$37.22 M
Est. $42.41 M

Next Earnings Call

Expected Date
February 26, 2027
EPS Estimate
$0.01
Consensus analyst estimate
Revenue Estimate
$41.96 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About SomnoMed Limited

300 employees
CEO: Karen Borg

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classi...